Associated Papers
Discriminating activating, deactivating and resistance variants in protein kinases.
Singh G et al.
Genome Medicine, 2025
41152984 (PubMed )
Supplement: 13073_2025_1564_MOESM2_ESM.xlsx › Table_S6
Genetic findings of children with congenital heart diseases using chromosomal microarray and trio-based whole exome sequencing.
Guo R et al.
Scientific Reports, 2025
40715143 (PubMed )
Supplement: 41598_2025_6977_MOESM2_ESM.xlsx › Sheet1
Blood Pressure-Associated Genetic Variants in the Natriuretic Peptide Receptor 1 Gene Modulate Guanylate Cyclase Activity.
Vandenwijngaert S et al.
Circulation. Genomic and Precision Medicine, 2019
Association of NPRA and NPRC gene variants and hypertension in Mongolian population.
Chang PY et al.
Genetics and Molecular Research : Gmr, 2015
Assessment of computational methods for predicting the effects of missense mutations in human cancers.
Gnad F et al.
Bmc Genomics, 2013
23819521 (PubMed )
Supplement: 1471-2164-14-S3-S7-S1.xlsx › dbSNP
Polymorphisms of beta-adrenoceptor and natriuretic peptide receptor genes influence the susceptibility to and the severity of idiopathic dilated cardiomyopathy in a Chinese cohort.
Wang L et al.
Journal of Cardiac Failure, 2010
Missense mutation of exon 3 in the type A human natriuretic peptide receptor gene is associated with myocardial infarction.
Nakayama T et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research, 2003
A novel missense mutation of exon 3 in the type A human natriuretic peptide receptor gene: possible association with essential hypertension.
Nakayama T et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension, 2002
Select a paper to view details